Recent Updates
Recently added Catalysts
BDX Positive Sentiment Score: 70/100

BD Announces Webcast of Annual Meeting of Shareholders BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will host a live webcast of its...

Key Takeaway: BD (Becton, Dickinson and Company) has announced the hosting of a live webcast for its Annual Meeting of Shareholders on January 23, 2024. This event will be available on BD's investor relations website, allowing shareholders and interested parties to access important company updates. The webcast reflects BD's commitment to engaging with its shareholders and fostering transparency. Following the live event, a replay will also be made available on the same website.

Market Sentiment Analysis

POSITIVE FACTORS

  • BD is hosting its Annual Meeting of Shareholders, indicating an engaged shareholder base.
  • The live webcast allows for broader access to company updates for investors.
  • BD continues to showcase its commitment to transparency and communication with stakeholders.

Full Press Release Details

FRANKLIN LAKES, N.J. , Jan. 5, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 23, 2024 , at 1:00 p.m. (ET) .
The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors and a replay will be available shortly after the call at the same website.
About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ , X (formerly Twitter) @BDandCo or Instagram @becton_dickinson .
Contacts:
Media : Investors :
Troy Kirkpatrick Adam Reiffe
VP, Public Relations Sr. Director, Investor Relations
858.617.2361 201.847.6927
[email protected] [email protected]
SOURCE BD (Becton, Dickinson and Company)

21 %

Frequently Asked Questions

When is BD's Annual Meeting of Shareholders?

BD's Annual Meeting of Shareholders is on January 23, 2024, at 1:00 p.m. ET.

How can I access the BD webcast?

You can access the webcast at BD's investor relations website, www.bd.com/investors.

Will there be a replay of the BD meeting?

Yes, a replay of the BD webcast will be available shortly after the meeting.

What is BD known for?

BD is a leading medical technology company improving medical discovery and care delivery.

How does BD support healthcare providers?

BD develops innovative technologies and solutions to enhance clinician care delivery.

Last updated: Jan 5, 2024